Todd Swarthout at University Medical Center Utrecht - Research Interests, Publications & Academic Profile

Todd Swarthout

Assistant Professor

University Medical Center Groningen

Netherlands

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Continue in dashboard

Contact this professor

ORCID

Google Scholar

Research Interests

Epidemiology

80%

Virology

40%

Molecular Epidemiology

50%

Vaccine Development

40%

Infectious Disease

40%

Disease Transmission

40%

Respiratory Infection

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

The impact of pneumococcal and malaria vaccines on bacterial resistance and antimicrobial use for febrile illness in young children in Malawi

Open Date: 2019-01-01

Close Date:

Grant: Close

An evaluation of the long-term effect of mass azithromycin administration in the MORDOR trial on Streptococcus pneumoniae antimicrobial resistance and population structure in Malawi

Open Date: 2019-01-01

Close Date:

Grant: Close

Evaluation of PCV vaccine schedules, comparing impact of 2+1 vs 3+0 on pneumococcal carriage

Open Date: 2019-01-01

Close Date:

Grant: Close

Duration and density of natural human pneumococcal colonisation in Malawian adults

Open Date: 2018-01-01

Close Date:

Articles15

A comparison of four epidemic waves of COVID-19 in Malawi; an observational cohort study.

Article Link

Year:

2023

Optimal age targeting for pneumococcal vaccination in older adults; a modelling study.

Article Link

Year:

2023

Different clinical features in Malawian outpatients presenting with COVID-19 prior to and during Omicron variant dominance: A prospective observational study

Article Link

Year:

2023

Cross-sectional health centre and community-based evaluation of the impact of pneumococcal and malaria vaccination on antibiotic prescription and usage, febrile illness and antimicrobial resistance in young children in Malawi: the IVAR study protocol

Article Link

Year:

2023

The metabolic, virulence and antimicrobial resistance profiles of colonising Streptococcus pneumoniae shift after PCV13 introduction in urban Malawi.

Article Link

Year:

2023

Invasiveness potential of pneumococcal serotypes in children after introduction of PCV13 in Blantyre, Malawi

Article Link

Year:

2023

Omicron B.1.1.529 variant infections associated with severe disease are uncommon in a COVID-19 under-vaccinated, high SARS-CoV-2 seroprevalence population in Malawi.

Article Link

Year:

2022

Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi.

Article Link

Year:

2022

Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation

Article Link

Year:

2022

Association between household air pollution and nasopharyngeal pneumococcal carriage in Malawian infants (MSCAPE): a nested, prospective, observational study

Article Link

Year:

2022

Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data

Article Link

Year:

2022

Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study

Article Link

Year:

2022

Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study

Article Link

Year:

2022

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

Article Link

Year:

2021

Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre, Malawi, 2006–18: prospective observational time-series and case-control studies

Article Link

Year:

2021

Collaborators14

Frank P. Mockenhaupt

GERMANY

View Details

Antonia Ho

Clinical Senior Lecturer

MRC-University of Glasgow Centre For Virus Research

UNITED KINGDOM

View Details

Simon Jochems

Assistant Professor

Leiden University Medical Center

NETHERLANDS

View Details

Kondwani Jambo

Reader in Immunology and Infection/ MRC African Research Leader

Liverpool School of Tropical Medicine

UNITED KINGDOM

View Details

Nigel Cunliffe

Professor

University of Liverpool

UNITED KINGDOM

View Details

Ben Morton

Senior Clinical Lecturer

Liverpool School of Tropical Medicine

UNITED KINGDOM

View Details

Nicholas Douglas

University of Otago

NEW ZEALAND

View Details

Didier Ménard

FRANCE

View Details

Melita Gordon

Professor

University of Liverpool

UNITED KINGDOM

View Details

Georgina Humphreys

University of Oxford

UNITED KINGDOM

View Details

Neil French

Professor of Infectious Disease & Global Health

UNITED KINGDOM

View Details

Johan Ursing

Karolinska Institutet Institutionen för klinisk forskning och utbildning Södersjukhuset

SWEDEN

View Details

Elizabeth Allen

University of Oxford

UNITED KINGDOM

View Details

Sam Salman

University of Western Australia

AUSTRALIA

View Details

How do I reach out?

Continue in dashboard